149 related articles for article (PubMed ID: 1695907)
1. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
Ziegler A; Hagmann J; Kiefer B; Nagamine Y
J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176
[TBL] [Abstract][Full Text] [Related]
3. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
Marksitzer R; Stief A; Menoud PA; Nagamine Y
J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeletal reorganization and TPA differently modify AP-1 to induce the urokinase-type plasminogen activator gene in LLC-PK1 cells.
Lee JS; von der Ahe D; Kiefer B; Nagamine Y
Nucleic Acids Res; 1993 Jul; 21(15):3365-72. PubMed ID: 8346015
[TBL] [Abstract][Full Text] [Related]
5. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition.
Nagamine Y; Ziegler A
EMBO J; 1991 Jan; 10(1):117-22. PubMed ID: 1846595
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
Ziegler A; Knesel J; Fabbro D; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
[TBL] [Abstract][Full Text] [Related]
7. Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells.
Santell L; Marotti K; Bartfeld NS; Baynham P; Levin EG
Exp Cell Res; 1992 Aug; 201(2):358-65. PubMed ID: 1639133
[TBL] [Abstract][Full Text] [Related]
8. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
Samarakoon R; Higgins PJ
J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
[TBL] [Abstract][Full Text] [Related]
9. Induction and desensitization of plasminogen activator gene expression by tumor promoters.
Degen JL; Estensen RD; Nagamine Y; Reich E
J Biol Chem; 1985 Oct; 260(23):12426-33. PubMed ID: 3862668
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cAMP-mediated gene induction: examination of renal epithelial cell mutants affected in the catalytic subunit of the cAMP-dependent protein kinase.
Pearson D; Nigg EA; Nagamine Y; Jans DA; Hemmings BA
Exp Cell Res; 1991 Jan; 192(1):315-8. PubMed ID: 1898592
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton.
Bayraktutan U; Jones P
Exp Cell Res; 1995 Dec; 221(2):486-95. PubMed ID: 7493649
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal reorganization leads to induction of the urokinase-type plasminogen activator gene by activating FAK and Src and subsequently the Ras/Erk signaling pathway.
Irigoyen JP; Nagamine Y
Biochem Biophys Res Commun; 1999 Sep; 262(3):666-70. PubMed ID: 10471383
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the cytoskeleton-extracellular matrix linkage promotes the accumulation of plasminogen activators in F9 derived parietal endoderm.
Snyder RW; Lenburg ME; Seebaum AT; Grabel LB
Differentiation; 1992 Aug; 50(3):153-62. PubMed ID: 1330791
[TBL] [Abstract][Full Text] [Related]
14. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y
Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499
[TBL] [Abstract][Full Text] [Related]
15. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
[TBL] [Abstract][Full Text] [Related]
16. LLC-PK1 cell mutants in cAMP metabolism respond normally to phorbol esters.
Jans DA; Hemmings BA
FEBS Lett; 1986 Sep; 205(1):127-31. PubMed ID: 3017754
[TBL] [Abstract][Full Text] [Related]
17. Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton.
Jans DA; Peters R; Jans P; Fahrenholz F
Exp Cell Res; 1990 Nov; 191(1):121-8. PubMed ID: 2146138
[TBL] [Abstract][Full Text] [Related]
18. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines.
Jans DA; Dierks-Ventling C; Hemmings BA
Exp Cell Res; 1987 Sep; 172(1):76-83. PubMed ID: 3653259
[TBL] [Abstract][Full Text] [Related]
19. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
Jans DA; Resink TJ; Hemmings BA
Biochem J; 1987 Apr; 243(2):413-8. PubMed ID: 2820380
[TBL] [Abstract][Full Text] [Related]
20. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
Niedbala MJ; Sartorelli AC
Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
